|
Market Closed -
Bombay S.E.
06:28:52 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 117.40 INR | +3.99% |
|
+21.51% | +185.85% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 18.52B 196M 169M 158M 145M 270M 272M 1.87B 729M 9.46B 736M 720M 30.48B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 196M 169M 158M 145M 270M 272M 1.87B 729M 9.46B 736M 720M 30.48B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | +3.99% | ||
| 1 week | +21.04% | ||
| Current month | +9.61% | ||
| 1 month | +105.96% | ||
| 3 months | +156.28% | ||
| 6 months | +181.67% | ||
| Current year | +185.85% |
| 1 week | 96.07 |  | 118.5 |
| 1 month | 55.93 | | 118.5 |
| Current year | 33.44 | | 118.5 |
| 1 year | 33.44 | | 118.5 |
| 3 years | 31.31 | | 118.5 |
| 5 years | 23.65 | | 118.5 |
| 10 years | 7.21 | | 118.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.99% | +21.04% | +142.06% | +202.97% | 655M | |
| -0.04% | -2.51% | +57.73% | +108.15% | 1,034B | |
| +1.17% | +3.12% | +56.37% | +73.50% | 663B | |
| -0.58% | -1.02% | +22.79% | +75.58% | 462B | |
| +2.09% | -3.20% | +36.07% | +37.41% | 344B | |
| 0.00% | +3.26% | +29.76% | +46.97% | 307B | |
| +1.42% | -0.72% | +2.03% | +13.51% | 251B | |
| +0.29% | +0.86% | +54.79% | +73.00% | 239B | |
| -0.03% | -1.11% | -15.87% | -53.65% | 207B | |
| +1.08% | +2.11% | +34.17% | +97.29% | 186B | |
| Average | +0.88% | +1.01% | +41.99% | +67.47% | 369.4B | |
| Weighted average by Cap. | +0.34% | -0.84% | +39.50% | +67.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 180M 155M 145M 133M 248M 250M 1.72B 670M 8.7B 676M 661M 28.01B | 18.12B 192M 165M 155M 142M 264M 266M 1.83B 713M 9.26B 720M 704M 29.82B |
| Net income | 962M 10.17M 8.75M 8.21M 7.51M 14.03M 14.14M 97.16M 37.84M 491M 38.2M 37.37M 1.58B | 1.18B 12.48M 10.74M 10.08M 9.22M 17.21M 17.35M 119M 46.44M 603M 46.88M 45.86M 1.94B |
| Net Debt | 121M 1.28M 1.1M 1.03M 942K 1.76M 1.77M 12.18M 4.74M 61.6M 4.79M 4.68M 198M | -928K -9.82K -8.45K -7.93K -7.25K -13.54K -13.64K -93.77K -36.52K -474K -36.86K -36.06K -1.53M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | ₹117.40 | +3.99% | 1,842,486 |
| 26-09-02 | ₹112.90 | +8.77% | 2,261,394 |
| 26-09-01 | ₹103.80 | -3.09% | 1,353,302 |
| 26-08-31 | ₹107.11 | +0.85% | 2,008,199 |
| 26-08-28 | ₹106.21 | +9.93% | 1,756,732 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
